Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment

(MedPage Today) -- Cancer-related cognitive impairment (CRCI) in breast cancer survivors improved significantly after treatment with the glutamate regulator oxaloacetate, a preliminary single-arm clinical study showed. All 16 evaluable patients...